FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 128 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,148,000 | +50.7% | 85,663 | +4.5% | 0.01% | +33.3% |
| Q4 2018 | $762,000 | -13.0% | 81,956 | +30.2% | 0.01% | 0.0% |
| Q3 2018 | $876,000 | +8.4% | 62,961 | +23.2% | 0.01% | +20.0% |
| Q2 2018 | $808,000 | +3.1% | 51,090 | +12.0% | 0.01% | -16.7% |
| Q1 2018 | $784,000 | +11.5% | 45,616 | +42.3% | 0.01% | +20.0% |
| Q4 2017 | $703,000 | -39.3% | 32,058 | +13.2% | 0.01% | -37.5% |
| Q3 2017 | $1,159,000 | +48.2% | 28,330 | +9.1% | 0.01% | +60.0% |
| Q2 2017 | $782,000 | -11.6% | 25,966 | +6.1% | 0.01% | -16.7% |
| Q1 2017 | $885,000 | -51.1% | 24,468 | -32.2% | 0.01% | -53.8% |
| Q4 2016 | $1,808,000 | -23.1% | 36,085 | -19.5% | 0.01% | -31.6% |
| Q3 2016 | $2,352,000 | +9.4% | 44,803 | -13.8% | 0.02% | 0.0% |
| Q2 2016 | $2,150,000 | +298.1% | 51,994 | +291.3% | 0.02% | +216.7% |
| Q1 2016 | $540,000 | – | 13,289 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|